Patents by Inventor Kyle Frantz

Kyle Frantz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050143295
    Abstract: This invention describes gene targets for the development of therapeutics to treat drug addiction. Animal models of drug craving and relapse have been developed and used to find gene expression changes in key brain regions implicated in cocaine addiction. The genes whose expression levels are altered serve as pharmacological targets with the purpose of preventing or inhibiting cocaine craving and relapse in human cocaine addicts.
    Type: Application
    Filed: October 6, 2003
    Publication date: June 30, 2005
    Applicant: IRM LLC
    Inventors: John Walker, David Self, Kyle Frantz